Index of artpub/2020/236099/

Weisel, K
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma : an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
2020
https://ddd.uab.cat/record/236099